Condition
Hyperuricemia or Gout
Total Trials
5
Recruiting
4
Active
4
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (1)
P 4 (2)
Trial Status
Recruiting4
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06834230Phase 4RecruitingPrimary
Effect of Dotinurad in Hyperuricemia With Hypertension
NCT07002762Not ApplicableRecruitingPrimary
Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia
NCT06966635Phase 4RecruitingPrimary
Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets
NCT06694012Recruiting
Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
NCT03923868Phase 1CompletedPrimary
D-0120 Safety and PK/PD Study in China
Showing all 5 trials